Indaptus Therapeutics completes $24 million private placement of common stock

Indaptus Therapeutics, Inc., a Delaware-based company with its headquarters in New York, recently completed a private placement of its common stock, raising approximately $24 million in gross proceeds. The company announced the successful completion of the transaction on October 16, 2026, following an initial agreement signed on September 8, 2026.

Indaptus issued a total of 20,338,974 shares, each with a par value of $0.01, to participating investors. The stock price of INDP jumped 14% over the past week, reaching $2.96 per share, but an analysis from InvestingPro indicates that the shares are currently overvalued relative to its Fair Value estimate.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.